EXPERT OPIN DRUG SAF 润色咨询

Expert Opinion On Drug Safety

出版年份：2002 年文章数：1611 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：2.9% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2270390, encodeId=44f622e039046, content=请教大家一个问题，我投了Expert Opinion on Drug Safety这个杂志，我收到校稿通知的邮件，但是邮件里面写的杂志名称是Expert Opinion on Drug Safety IEDS，多了一个IEDS，我在网上没有查到IEDS这个后缀的意思，有这个后缀是正常的吗？Expert Opinion on Drug Safety IEDS和Expert Opinion on Drug Safety是一个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=qUzDoicVlsBliaye8YTDM2icA&s=100, createdBy=7e305078170, createdName=yangjing_0617, createdTime=Sun Jun 22 15:57:50 CST 2025, time=2025-06-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2118891, encodeId=cbb1211889105, content=审稿速度:3.0<br>经验分享：投了一篇，一审大概要13周。审稿人的意见对提升文章质量非常有益。这个杂志的总体工作效率一般，如果不是很着急，可以投这个杂志。也能从投稿中学习到很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde48390454, createdName=ms5000001724846126, createdTime=Sat Mar 11 09:57:59 CST 2023, time=2023-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225020, encodeId=9852122502012, content=请问投稿过后大概多久编辑会看到啊，投了五天了都还是awaiting commissioning editor processing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=696f5679181, createdName=ms5000001492181188, createdTime=Tue Jun 07 17:43:02 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811909, encodeId=530081190983, content=最近为什么都没人投了呀，一审意见我感觉挺友好的。有谁知道二审大概多久能接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Fri Aug 21 22:11:19 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100163, encodeId=a0af110016331, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100164, encodeId=ba0211001642b, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2025-06-22 yangjing_0617 来自四川省

    请教大家一个问题，我投了Expert Opinion on Drug Safety这个杂志，我收到校稿通知的邮件，但是邮件里面写的杂志名称是Expert Opinion on Drug Safety IEDS，多了一个IEDS，我在网上没有查到IEDS这个后缀的意思，有这个后缀是正常的吗？Expert Opinion on Drug Safety IEDS和Expert Opinion on Drug Safety是一个杂志吗？

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2270390, encodeId=44f622e039046, content=请教大家一个问题，我投了Expert Opinion on Drug Safety这个杂志，我收到校稿通知的邮件，但是邮件里面写的杂志名称是Expert Opinion on Drug Safety IEDS，多了一个IEDS，我在网上没有查到IEDS这个后缀的意思，有这个后缀是正常的吗？Expert Opinion on Drug Safety IEDS和Expert Opinion on Drug Safety是一个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=qUzDoicVlsBliaye8YTDM2icA&s=100, createdBy=7e305078170, createdName=yangjing_0617, createdTime=Sun Jun 22 15:57:50 CST 2025, time=2025-06-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2118891, encodeId=cbb1211889105, content=审稿速度:3.0<br>经验分享：投了一篇，一审大概要13周。审稿人的意见对提升文章质量非常有益。这个杂志的总体工作效率一般，如果不是很着急，可以投这个杂志。也能从投稿中学习到很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde48390454, createdName=ms5000001724846126, createdTime=Sat Mar 11 09:57:59 CST 2023, time=2023-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225020, encodeId=9852122502012, content=请问投稿过后大概多久编辑会看到啊，投了五天了都还是awaiting commissioning editor processing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=696f5679181, createdName=ms5000001492181188, createdTime=Tue Jun 07 17:43:02 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811909, encodeId=530081190983, content=最近为什么都没人投了呀，一审意见我感觉挺友好的。有谁知道二审大概多久能接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Fri Aug 21 22:11:19 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100163, encodeId=a0af110016331, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100164, encodeId=ba0211001642b, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2023-03-11 ms5000001724846126

    审稿速度:3.0
    经验分享：投了一篇，一审大概要13周。审稿人的意见对提升文章质量非常有益。这个杂志的总体工作效率一般，如果不是很着急，可以投这个杂志。也能从投稿中学习到很多。

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2270390, encodeId=44f622e039046, content=请教大家一个问题，我投了Expert Opinion on Drug Safety这个杂志，我收到校稿通知的邮件，但是邮件里面写的杂志名称是Expert Opinion on Drug Safety IEDS，多了一个IEDS，我在网上没有查到IEDS这个后缀的意思，有这个后缀是正常的吗？Expert Opinion on Drug Safety IEDS和Expert Opinion on Drug Safety是一个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=qUzDoicVlsBliaye8YTDM2icA&s=100, createdBy=7e305078170, createdName=yangjing_0617, createdTime=Sun Jun 22 15:57:50 CST 2025, time=2025-06-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2118891, encodeId=cbb1211889105, content=审稿速度:3.0<br>经验分享：投了一篇，一审大概要13周。审稿人的意见对提升文章质量非常有益。这个杂志的总体工作效率一般，如果不是很着急，可以投这个杂志。也能从投稿中学习到很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde48390454, createdName=ms5000001724846126, createdTime=Sat Mar 11 09:57:59 CST 2023, time=2023-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225020, encodeId=9852122502012, content=请问投稿过后大概多久编辑会看到啊，投了五天了都还是awaiting commissioning editor processing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=696f5679181, createdName=ms5000001492181188, createdTime=Tue Jun 07 17:43:02 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811909, encodeId=530081190983, content=最近为什么都没人投了呀，一审意见我感觉挺友好的。有谁知道二审大概多久能接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Fri Aug 21 22:11:19 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100163, encodeId=a0af110016331, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100164, encodeId=ba0211001642b, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2022-06-07 ms5000001492181188

    请问投稿过后大概多久编辑会看到啊，投了五天了都还是awaiting commissioning editor processing

    4

    展开4条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2270390, encodeId=44f622e039046, content=请教大家一个问题，我投了Expert Opinion on Drug Safety这个杂志，我收到校稿通知的邮件，但是邮件里面写的杂志名称是Expert Opinion on Drug Safety IEDS，多了一个IEDS，我在网上没有查到IEDS这个后缀的意思，有这个后缀是正常的吗？Expert Opinion on Drug Safety IEDS和Expert Opinion on Drug Safety是一个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=qUzDoicVlsBliaye8YTDM2icA&s=100, createdBy=7e305078170, createdName=yangjing_0617, createdTime=Sun Jun 22 15:57:50 CST 2025, time=2025-06-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2118891, encodeId=cbb1211889105, content=审稿速度:3.0<br>经验分享：投了一篇，一审大概要13周。审稿人的意见对提升文章质量非常有益。这个杂志的总体工作效率一般，如果不是很着急，可以投这个杂志。也能从投稿中学习到很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde48390454, createdName=ms5000001724846126, createdTime=Sat Mar 11 09:57:59 CST 2023, time=2023-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225020, encodeId=9852122502012, content=请问投稿过后大概多久编辑会看到啊，投了五天了都还是awaiting commissioning editor processing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=696f5679181, createdName=ms5000001492181188, createdTime=Tue Jun 07 17:43:02 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811909, encodeId=530081190983, content=最近为什么都没人投了呀，一审意见我感觉挺友好的。有谁知道二审大概多久能接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Fri Aug 21 22:11:19 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100163, encodeId=a0af110016331, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100164, encodeId=ba0211001642b, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2020-08-21 146f6ef6m90(暂无昵称)

    最近为什么都没人投了呀，一审意见我感觉挺友好的。有谁知道二审大概多久能接收吗

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2270390, encodeId=44f622e039046, content=请教大家一个问题，我投了Expert Opinion on Drug Safety这个杂志，我收到校稿通知的邮件，但是邮件里面写的杂志名称是Expert Opinion on Drug Safety IEDS，多了一个IEDS，我在网上没有查到IEDS这个后缀的意思，有这个后缀是正常的吗？Expert Opinion on Drug Safety IEDS和Expert Opinion on Drug Safety是一个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=qUzDoicVlsBliaye8YTDM2icA&s=100, createdBy=7e305078170, createdName=yangjing_0617, createdTime=Sun Jun 22 15:57:50 CST 2025, time=2025-06-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2118891, encodeId=cbb1211889105, content=审稿速度:3.0<br>经验分享：投了一篇，一审大概要13周。审稿人的意见对提升文章质量非常有益。这个杂志的总体工作效率一般，如果不是很着急，可以投这个杂志。也能从投稿中学习到很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde48390454, createdName=ms5000001724846126, createdTime=Sat Mar 11 09:57:59 CST 2023, time=2023-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225020, encodeId=9852122502012, content=请问投稿过后大概多久编辑会看到啊，投了五天了都还是awaiting commissioning editor processing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=696f5679181, createdName=ms5000001492181188, createdTime=Tue Jun 07 17:43:02 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811909, encodeId=530081190983, content=最近为什么都没人投了呀，一审意见我感觉挺友好的。有谁知道二审大概多久能接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Fri Aug 21 22:11:19 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100163, encodeId=a0af110016331, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100164, encodeId=ba0211001642b, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-28 衣谷

    和讨论比，引言撰写的方式有什么不同？

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2270390, encodeId=44f622e039046, content=请教大家一个问题，我投了Expert Opinion on Drug Safety这个杂志，我收到校稿通知的邮件，但是邮件里面写的杂志名称是Expert Opinion on Drug Safety IEDS，多了一个IEDS，我在网上没有查到IEDS这个后缀的意思，有这个后缀是正常的吗？Expert Opinion on Drug Safety IEDS和Expert Opinion on Drug Safety是一个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=qUzDoicVlsBliaye8YTDM2icA&s=100, createdBy=7e305078170, createdName=yangjing_0617, createdTime=Sun Jun 22 15:57:50 CST 2025, time=2025-06-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2118891, encodeId=cbb1211889105, content=审稿速度:3.0<br>经验分享：投了一篇，一审大概要13周。审稿人的意见对提升文章质量非常有益。这个杂志的总体工作效率一般，如果不是很着急，可以投这个杂志。也能从投稿中学习到很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde48390454, createdName=ms5000001724846126, createdTime=Sat Mar 11 09:57:59 CST 2023, time=2023-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225020, encodeId=9852122502012, content=请问投稿过后大概多久编辑会看到啊，投了五天了都还是awaiting commissioning editor processing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=696f5679181, createdName=ms5000001492181188, createdTime=Tue Jun 07 17:43:02 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811909, encodeId=530081190983, content=最近为什么都没人投了呀，一审意见我感觉挺友好的。有谁知道二审大概多久能接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Fri Aug 21 22:11:19 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100163, encodeId=a0af110016331, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100164, encodeId=ba0211001642b, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-28 MS68862005

    引言一般是三段式么？

    1

    展开1条回复
共16条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分